USPTO serial 79438995
KIMILOID
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- HUSSAIN, TASNEEM
- Law office
- TMO LAW OFFICE 118
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with KIMILOID?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kumiko Ide
Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.1150 Connecticut Avenue, NW, Suite 505Washington, DC 20036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals, namely, alginates for industrial purposes; chemicals, namely, alginates for the food industry; chemicals, namely, alginates for culinary purposes; alginates for the food industry; alginates for industrial purposes; chemical additives for use in the manufacture of medicines; reagents for scientific, laboratory or research use, other than for medical or veterinary use; improvers for food being chemical additives for use in the manufacture of food; seaweed-based chemical additives for use in the manufacture of food; dough stabilizers for the food industry; chemical substances for stabilising foodstuffs; chemicals for use in the manufacture of pharmaceuticals, cosmetics and foodstuffs; chemicals for use in printing for textile as fixing solutions, namely, printing paste and color enhancer for printing textiles | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of peptic ulcers; pharmaceutical preparations, namely, antacids; pharmaceutical preparations, namely, adjuvants for medical purposes; pharmaceutical preparations, namely, eye drops; pharmaceutical preparations, namely, wound dressings; pharmaceutical preparations being natural biomaterials for augmentation of bone and tissue for medical purposes; alginates for pharmaceutical purposes; processed foodstuffs, namely, dietary food supplements in powder, granulated, capsule or tablet form, mainly from alginic acid, for medical, pharmaceutical, and health purposes; alginate dietary supplements; dietary supplements for humans; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; diet capsules; capsules sold empty for pharmaceuticals; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies, namely, liquid formula milk for babies; dietetic beverages for babies adapted for medical purpose; food for babies; dietary supplements for animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 10, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 10, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 10, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 31, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 26, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 12, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 11, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 15, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 14, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 12, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 11, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |